简介内容:CP19, a histamine receptor antagonist, serves as an entry inhibitor for Ebolavirus (EBOV) and Marburgvirus (MARV), exhibiting inhibitory concentrations (IC50s) of μM for EBOV and μM for MARV, respectively. It demonstrates selective index (SI) values of for EBOV and for MARV, indicating its antiviral activity against these viruses.